Roche says did not collude with Novartis to restrict competition
ZURICH (Reuters) - Swiss drugmaker Roche said on Thursday that it had not colluded with Novartis to restrict competition for eye disease treatments.
"Roche confirms there is no agreement between Roche and Novartis that restricts competition," the drugmaker said in a statement.
Earlier on Thursday, the companies said France's competition authority was investigating them on suspicion they were involved in anti-competitive practices in relation to treatment for wet age-related macular degeneration (AMD).
(Reporting by Caroline Copley; Editing by Pravin Char)
- California passes 'yes-means-yes' campus sexual assault bill
- IBM launches Watson system for research, hopes for breakthroughs
- Separatists say will allow 'trapped' Ukrainian forces to withdraw |
- In town halls, U.S. lawmakers hear voter anger over illegal migrants |
- U.N. says 43 Golan peacekeepers seized by Syria militants, 81 trapped